Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis

Journal of Allergy and Clinical Immunology

Volumn 117, Issue 2, 2006, Pages 319-325

  Frew, Anthony J ^a,e,f   Powell, Richard J ^b,g   Corrigan, Christopher J ^c   Durham, Stephen R ^d,g  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b QUEEN S MEDICAL CENTRE   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d ROYAL BROMPTON HOSPITAL   (United Kingdom)

^e BRIGHTON GENERAL HOSPITAL   (United Kingdom)

^f Novartis   (Germany)

^g ALK Abelló ^*

Author keywords

Allergic rhinitis; Efficacy; Grass pollen; Immunotherapy; Quality of life; Safety

Indexed keywords

ACRIVASTINE; ALUTARD; CROMOGLYCATE DISODIUM; FLUTICASONE PROPIONATE; PLACEBO;

ADULT; ANGIONEUROTIC EDEMA; ARTICLE; ASTHMA; CLINICAL TRIAL; CONJUNCTIVITIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG USE; FATIGUE; FEMALE; HAY FEVER; HEADACHE; HUMAN; IMMUNOTHERAPY; INJECTION SITE DISCOMFORT; INJECTION SITE REACTION; INJECTION SITE SWELLING; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PRURITUS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SYMPTOM; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; URTICARIA; WHEEZING;

ADOLESCENT; ADULT; ALLERGENS; CONJUNCTIVITIS, ALLERGIC; DESENSITIZATION, IMMUNOLOGIC; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; PHLEUM; PLANT EXTRACTS; POLLEN; QUALITY OF LIFE; RHINITIS, ALLERGIC, SEASONAL; TREATMENT OUTCOME;

EID: 31944443997     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2005.11.014     Document Type: Article

References (17)

1. J. Bousquet, P. Van Cauwenberge, and N. Khaltaev Allergic rhinitis and its impact on asthma J Allergy Clin Immunol 108 suppl 2001 S147 S334
2. J. Bousquet, R. Lockey, and H.J. Malling Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper J Allergy Clin Immunol 102 1998 558 562
3. A.M. Ross, and D.M. Fleming Incidence of allergic rhinitis in general practice, 1981-1992 BMJ 308 1994 897 900
4. P. White, H. Smith, N. Baker, W. Davis, and A. Frew Symptom control in patients with hay fever in UK general practice: how well are we doing and is there a need for allergen immunotherapy? Clin Exp Allergy 28 1998 266 270
5. H.J. Malling, and B. Weeke Immunotherapy. Position Paper of the European Academy of Allergology and Clinical Immunology Allergy 48 1993 9 35
6. E.F. Juniper, and G.H. Guyatt Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis Clin Exp Allergy 21 1991 77 83
7. V.A. Varney, M. Gaga, A.J. Frew, V.R. Aber, A.B. Kay, and S.R. Durham Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by antiallergic drugs BMJ 302 1991 265 269
8. S.M. Walker, G.B. Pajno, M.T. Lima, D.R. Wilson, and S.R. Durham Grass pollen immunotherapy for seasonal rhinitis and asthma: a randomized, controlled trial J Allergy Clin Immunol 107 2001 87 93
9. L. Haugaard, R. Dahl, and L. Jacobsen A controlled dose-response study of immunotherapy with standardized, partially purified extract of house dust mite: clinical efficacy and side effects J Allergy Clin Immunol 91 1993 709 722
10. S.M. Walker, V.A. Varney, M. Gaga, M.R. Jacobson, and S.R. Durham Grass pollen immunotherapy: efficacy and safety during a 4-year follow-up study Allergy 50 1995 405 413
11. M.B. Arvidsson, O. Lowhagen, and S. Rak Effect of 2-year placebo-controlled immunotherapy on airway symptoms and medication in patients with birch pollen allergy J Allergy Clin Immunol 109 2002 777 783
12. C.E. Pichler, A. Helbling, and W.J. Pichler Three years of SIT with house-dust-mite extracts in patients with rhinitis and asthma: significant improvement of allergen-specific parameters and of nonspecific bronchial hyperreactivity Allergy 56 2001 301 306
13. S.R. Durham, S.M. Walker, E.M. Varga, M.R. Jacobson, F. O'Brien, and W. Noble Long-term clinical efficacy of grass-pollen immunotherapy N Engl J Med 341 1999 468 475
14. A. Des Roches, L. Paradis, J.L. Menardo, S. Bouges, J.P. Daures, and J. Bousquet Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children J Allergy Clin Immunol 99 1997 450 453
15. G.B. Pajno, G. Barberio, F. De Luca, L. Morabito, and S. Parmiani Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study Clin Exp Allergy 31 2001 1392 1397
16. F. Purello-D'Ambrosio, S. Gangemi, R.A. Merendino, S. Isola, P. Puccinelli, and S. Parmiani Prevention of new sensitizations in monosensitized subjects submitted to specific immunotherapy or not. A retrospective study Clin Exp Allergy 31 2001 1295 1302
17. C. Moller, S. Dreborg, H.A. Ferdousi, S. Halken, A. Host, and L. Jacobsen Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study) J Allergy Clin Immunol 109 2002 251 256